Disorders of Histiocytes

Hematopathology

Volumn , Issue , 2012, Pages 549-587

  Jaffe, Ronald ^a,b   Chikwava, Kudakwashe ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942330565     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2606-0.00019-6     Document Type: Chapter

References (99)

1. C Auffray, MH Sieweke and F Geissmann (2009) Blood monocytes: Development, heterogeneity and relationship with dendritic cells. Annu Rev Immunol 27 669-692.
2. M Cella, D Jarrossay, F Facchetti, et al. (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type 1 interferon. Nat Med 8 919-923.
3. S Doulatov, F Notta, K Eppert, et al. (2010) Revised map of the human progenitor hierarchy shows origin of macrophages and dendritic cells in early development. Nature Immunol 11 585-593.
4. F Geissmann, MG Manz, S Jung, et al. (2010) Development of monocytes, macrophages and dendritic cells. Science 327 656-661.
5. DNJ Hart (2004) Dendritic cell biology and its emerging place in clinical practice. Pathol Int 54(Suppl 1), S94-S102.
6. M Merad, F Ginjoux and M Collin (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8 935-947.
7. Z Stark and R Savarirayan (2009) Osteopetrosis. Orphanet J Rare Dis 4 5.
8. RM Steinman and ZA Cohn (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. Morphology, quantitation, tissue distribution. J Exp Med 137 1142-1162.
9. RD Stout and J Suttles (2004) Functional plasticity of macrophages: Reversible adaptation to changing microenvironments. J Leukoc Biol 76 509-513.
10. DNJ Hart, K MacDonald, S Vuckovic, et al. (2001) Phenotypic characterization of dendritic cells. MT Lotze, AW Thomson,(Eds) Dendritic Cells ed 2 San Diego: Academic Press 97-117.
11. SK Law, PG Chu and LM Weiss (2004) CD163. A specific marker of macrophage in paraffin-embedded tissue samples. Am J Clin Pathol 122 794-801.
12. MT Lotze and R Jaffe (2001) The identification of dendritic cells in cancer. MT Lotze, AW Thompson,(Eds) Dendritic Cells ed 2 San Diego: Academic Press 97-117.
13. K Maeda, M Matsuda, H Suzuki, et al. (2002) Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed parafin sections. J Histochem Cytochem 50 1475-1486.
14. D Muirhead, MS Stone and SI Syrbu (2009) The utility of PU1 as an immunohistochemical marker for histiocytic and dendritic cell lesions of the skin. Am J Dermatopathol 31 432-435.
15. LM Weiss, DA Arber and KL Chang (1994) CD68. A review. Appl Immunohistochem 2 2-8.
16. RS Neiman and A Orazi (Eds) (1999) ed 2 Disorders of the Spleen. Major Problems in Pathology vol 38 Philadelphia: Saunders 171-173.
17. F Geissmann, MC Dieu-Nosjean, C Dezutter, et al. (2002) Accumulation of immature Langerhans’ cells in human lymph nodes draining chronically inflamed skin. J Exp Med 196 417-430.
18. DA Lammas, E DeHeer, JN Edgar, et al. (2002) Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int J Exp Pathol 83 1-20.
19. O Ardeniz and C Cunningham-Rundles (2009) Granulomatous disease in common variable immunodeficiency. Clin Immunol 2 198-207.
20. A Borzutzky, A Fried, J Chou, et al. (2010) NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol 134 251-261.
21. T Niehues, R Perez-Becker and C Schuetz (2010) More than just SCID-The phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol 135 183-192.
22. EJ Parkinson-Lawrence, T Shandala, M Prodoehl, et al. (2010) Lysosomal storage disease: Revealing lysosomal function and physiology. Physiology 25 102-115.
23. J Stoevesandt, H Morbach, TM Martin, et al. (2010) Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol 27 69-73.
24. W Symmers and C St. (1992) Sarcoidosis and other varieties of granulomatous lymphadenitis of uncertain cause. K Henry, W Symmers, C St.,(Eds) Systemic Pathology, Volume 7, Thymus, Lymph Nodes, Spleen and Lymphatics ed 3 Edinburgh: Churchill Livingstone
25. K Takahashi, M Takeya and N Sakashita (2002) Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35 179-203.
26. S Gordon (2007) The macrophage: Past, present & future. Eur J Immunol 37(Suppl 1), S9-S17.
27. BE Favara, R Jaffe and RM Egeler (2002) Macrophage activation and hemophagocytic syndrome in Langerhans’ cell histiocytosis. Report of 30 cases. Pediatr Dev Pathol 5 130-140.
28. A Filipovich, K McClain and A Grom (2010) Histiocytic disorders: Recent insights into pathophysiology and current guidelines. Biol Blood Marrow Transplant 16(Suppl 1), 82-89.
29. AA Grom and ED Melins (2010) Macrophage activation syndrome: Advances towards understanding pathogenesis. Curr Opin Rheumatol 22 561-566.
30. AJ Rees (2010) Monocyte and macrophage biology: An overview. Semin Nephrol 3 216-233.
31. JH Chen, MD Fleming, GS Pinkus, et al. (2010) Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol 34 852-867.
32. JW Farquhar and AE Claireaux (1952) Familial hemophagocytic reticulosis. Arch Dis Child 136 519-525.
33. AH Filipovich (2009) Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 127-131.
34. R Jaffe (2005) The histopathology of hemophagocytic lymphohistiocytosis. RM Egeler, S Weitzman,(Eds) The Histiocytosis Cambridge 321-336.
35. G Janka (2009) Hemophagocytic lymphohistiocytosis: When the immune system runs amok. Klin Padiatr 5 278-285.
36. Å Öst, S Nilsson-Ardnor and JI Henter (1998) Autopsy findings in 27 children with hemophagocytic lymphohistiocytosis. Histopathology 32 310-316.
37. J Pachlopnik Schmid, M Cote, MM Menager, et al. (2010) Inherited defects in lymphocyte cytotoxic activity. Immunol Rev 235 10-23.
38. E Foucar, J Rosai and R Dorfman (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Review of the entity. Semin Diagn Pathol 7 19-73.
39. S Gaitonde (2007) Multifocal, extranodal sinus histiocytosis with massive lymphadenopathy: An overview. Arch Pathol Lab Med 131 1117-1121.
40. J Rosai and RF Dorfman (1972) Sinus histiocytosis with massive lymphadenopathy: A pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 30 1174-1188.
41. M Meittinen and JF Fetsch (2006) Reticulohistiocytoma (solitary epithelioid histiocytoma): A clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 30 521-528.
42. JD Outland, SJ Keiran, N Schikler, et al. (2002) Multicentric reticulohistiocytosis in a 14-year old girl. Pediatr Dermatol 19 527-531.
43. B Zelger, R Cerio, HP Soyer, et al. (1994) Reticulohistiocytoma and multicentric reticulohistiocytosis. Histopathologic and immunophenotypic distinct entities. Am J Dermatopathol 16 577-584.
44. O Abla, RM Egeler and S Weitzman (2010) Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev 36 354-359.
45. CE Allen, L Li, TL Peters, et al. (2010) Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184 4557-4567.
46. M Arico, M Girschikofsky, T Genereau, et al. (2003) Langerhans’ cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39 2341-2348.
47. G Badalinan-Very, JA Vergilio, BA Degar, et al. (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116 1919-1923.
48. RM Egeler, AG van Halteren, PC Hogenfoorn, et al. (2010) Langerhans cell histiocytosis: Fascinating dynamics of the dendritic cell-macrophage lineage. Immunol Rev 234 213-232.
49. H Gadner, N Grois, M Arico, et al. (2001) A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J Pediatr 138 728-734.
50. F Geismann, Y Lepelletier, S Fraitag, et al. (2001) Differentiation of Langerhans’ cells in Langerhans’ cell histiocytosis. Blood 97 1241-1248.
51. M Phillips, C Allen, P Gerson, et al. (2009) Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52 97-101.
52. D Prayer, N Grois, H Prosch, et al. (2004) MR imaging presentation of intracranial disease associated with Langerhans’ cell histiocytosis. Am J Neuroradiol 25 880-891.
53. L Refabert, C Rambaud, T Mamou-Mani, et al. (1996) CD1a-positive Cells in brochoalveolar lavage samples from children with Langerhans’ cell histiocytosis. J Pediatr 129 913-915.
54. J Valladeau, C Dezutter-Dambuyant and S Saeland (2003) Langerin/CD207 sheds light on formation of Birbeck granules and their possible function in Langerhans’ cells. Immunol Res 28 93-107.
55. CL Willman, L Busque, BB Griffith, et al. (1994) Langerhans’ cell histiocytosis (histiocytosis X): A clonal proliferative disease. N Engl J Med 331 154-160.
56. L Arnaud, Z Malek, F Archambaud, et al. (2009) 18 F—fluorodeoxyglucose-positron emission tomography scanning is more useful in follow up than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 60 3128-3138.
57. M Bisceglia, M Cammisa, S Suster, et al. (2003) Erdheim-Chester disease: Clinical and pathologic spectrum of four cases from the Arkadi M Rywlin slide seminars. Adv Anat Pathol 10 160-171.
58. LP Dehner (2003) Juvenile xanthogranulomas in the first two decades of life: A clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 27 579-593.
59. DR Freyer, R Kennedy, BC Bostrom, et al. (1996) Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications. J Pediatr 129 227-237.
60. J Guo and J Wang (2009) Adult orbital xanthogranulomatous disease: Review of the literature. Arch Pathol Lab Med 133 1994-1997.
61. DG Stover, S Alapati, O Regueira, et al. (2008) Treatment of juvenile xanthogranuloma. Pediatr Blood Cancer 51 130-133.
62. C Veyssier-Belot, P Cacoub, D Caparros-Lefebvre, et al. (1996) Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine 75 157-169.
63. AJ Wood, MV Wagner, JJ Abbott, et al. (2009) Necrobiotic xanthogranuloma: A review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol 145 279-284.
64. BW Zelger and R Cerio (2001) Xanthogranuloma is the archetype of non-Langerhans’ cell histiocytosis. Br J Dermatol 45 369-371.
65. M Flores-Stadler, F Gonzalez-Gussi, M Greene, et al. (1999) Indeterminate cell histiocytosis: Immunophenotypic and cytogenetic findings in children and infants. Med Pediatr Oncol 32 250-254.
66. R Jaffe and BE Favara (2002) Non-Langerhans’ dendritic cell histiocytosis. Pediatr Dev Pathol 5 99. (abstract)
67. SA Rezk, DV Spagnolo, RK Brynes, et al. (2008) Indeterminate cell tumor: A rare dendritic neoplasm. Am J Surg Pathol 32 1868-1876.
68. A Sidoroff, B Zelger, H Steiner, et al. (1996) Indeterminate cell histiocytosis—a clinicopathological entity with features of both X- and non-X histiocytosis. Br J Dermatol 134 525-532.
69. S Weitzman and R Jaffe (2005) Uncommon histiocytic disorders. The non-Langerhans’ cell histiocytoses. Pediatr Blood Cancer 256-264.
70. VP Andrade, CCV Nemer, ANL Prezotti, et al. (2004) Erdheim-Chester disease of the breast associated with Langerhans’ cell histiocytosis of the hard palate. Virch Arch 445 405-409.
71. PH Hoeger, C Diaz, M Malone, et al. (2001) Juvenile xanthogranuloma as a sequel to Langerhans’ cell histiocytosis: A report of three cases. Clin Exp Dermatol 26 391-394.
72. JW Tsai, JH Tsou, LY Hung, et al. (2010) Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: A rare case with human androgen-receptor gene analysis. J Am Acad Dematol 63 284-291.
73. DP O’Malley, A Duong, TS Barry, et al. (23:1616–1623, 2010) Co-occurence of Langerhans cell histiocytosis and Rosai-Dorfman diseases: Possible relationship of two histiocytic disorders in rare cases,. Mod Pathol
74. EC Castro, C Blazquez, J Boyd, et al. (2010) Clinicopathologic features of histiocytic lesions following ALL with a review of the literature. Pediatr Dev Pathol 13 225-237.
75. AL Feldman, DA Arber, S Pittaluga, et al. (2008) Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: Evidence for transdifferentiation of the follicular lymphoma clone. Blood 111 5433-5439.
76. C Copie-Bergman, AC Wotherspoon, AJ Norton, et al. (1998) True histiocytic lymphoma: A morphologic, immunohistochemical and molecular genetic study of 13 cases. Am J Surg Pathol 22 1386-1392.
77. AL Feldman, C Minniti, M Santi, et al. (2004) Histiocytic sarcoma after acute lymphoblastic leukemia: a common clonal origin. Lancet Oncol 5 248-250.
78. T Grogan, SA Pileri, JKC Chan, et al. (2008) Histiocytic sarcoma. SH Swerdlow, E Campo, NL Harris, et al., (Eds) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissue Lyon: IARC 356-357.
79. JA Vos, SL Abbondanzo, CL Barekman, et al. (2005) Histiocytic sarcoma: A study of five cases including the histiocyte marker CD163. Mod Pathol 18 693-704.
80. R Jaffe, LM Weiss, F Facchetti (2008) Tumours derived from Langerhans cells. SH Swerdlow, E Campo, NL Harris, et al., (Eds) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissue Lyon: IARC 358-360.
81. T Kawase, M Hamazaki, M Ogura, et al. (2008) CD56/NCAM-positive Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 32 615-619.
82. SA Pileri, TM Grogan, NL Harris, et al. (2002) Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41 1-29.
83. CA Feltkamp, P van Heerde, TM Feltkamp-Vroom, et al. (1981) A malignant tumour arising from interdigitating cells: light microscopical, ultrastructural, immuno and enzyme-histochemical characteristics. Virchows Arch A Pathol Anat Histol 393 183-192.
84. EM Gaertner, M Tsokos, GA Derringer, et al. (2001) Interdigitating cell sarcoma. A report of four cases and review of the literature. Am J Clin Pathol 115 589-597.
85. SA Pileri, TM Grogan, NL Harris, et al. (2002) Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41 1-29.
86. K Pillay, R Solomon, JD Daubenton, et al. (2004) Interdigitating dendritic cell sarcoma: A report of four paediatric cases and review of the literature. Histopathology 44 283-291.
87. LM Weiss, TM Grogan, JKC Chan (2008) Interdigitating cell sarcoma. SH Swerdlow, E Campo, NL Harris, et al., (Eds) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissue Lyon: IARC 361-362.
88. JK Chan, CD Fletcher, SJ Nayler, et al. (1997) Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 79 294-313.
89. JKC Chan, SA Pileri, G Delsol, et al. (2008) Follicular dendritic cell sarcoma. SH Swerdlow, E Campo, NL Harris, et al., (Eds) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissue Lyon: IARC 363-364.
90. W Cheuk, JK Chan, TW Shek, et al. (2001) Inflammatory pseudotumor-like follicular dendritic cell tumor: A distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol 25 721-731.
91. DM Cronin and RA Warnke (2009) Castleman disease: An update on classification and the spectrum of associated lesions. Adv Anat Pathol 16 236-246.
92. KL Grogg, ME Lae, PJ Kurtin, et al. (2004) Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: Report of a novel/dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28 988-998.
93. SA Pileri, TM Grogan, NL Harris, et al. (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to Classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41 1-29.
94. AD Saiz, O Chan and JA Strauchen (1997) Follicular dendritic cell tumor in Castleman's Disease. A report of two cases. Int J Surg Pathol 5 25-30.
95. GB Taylor and LW Smeeton (2000) Cytologic demonstration of “dysplastic” follicular dendritic cells in a case of hyaline-vascular Castleman's disease. Diagn Cytopathol 22 230-234.
96. U Ernemann, M Skalej, M Hermisson, et al. (2002) Primary cerebral non-Langerhans’ cell histiocytosis: MRI and differential diagnosis. Neuroradiology 44 759-763.
97. A Orsey, M Paessler, BJ Lange, et al. (2008) Central nervous system juvenile xanthogranuloma with malignant transformation. Pediatr Blood Cancer 50 927-930.
98. JW Andriko, EP Kaldjian, M Tsokos, et al. (1998) Reticulum cell neoplasms of lymph nodes: A clinicopathologic study of 11 cases with recognition of a new subtype derived from fibroblastic reticular cells. Am J Surg Pathol 22 1048-1058.
99. AC Chan, J Serrano-Olmo, RA Erlandson, et al. (2000) Cytokeratin-positive malignant tumor with reticulum cell morphology: A subtype of fibroblastic reticulum cell neoplasm? Am J Surg Pathol 24 107-116.